Lineage Cell Therapeutics Inc Long-term Investment Intensity
Lineage Cell Therapeutics Inc long-term investment intensity. Lineage Cell Therapeutics Inc (LCTX) has a Long-term Investment Intensity of 39.2% as of June 2019. Long-term investments of $59.40 Million represent 39.2% of total assets of $151.69 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read LCTX total liabilities for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Lineage Cell Therapeutics Inc (2015–2018)
Long-term investment intensity of Lineage Cell Therapeutics Inc from 2015 to 2018. This chart shows how Lineage Cell Therapeutics Inc's Long-term Investment Intensity has evolved across 4 annual periods from 2015 to 2018. As of June 2019, the intensity stands at 39.2%, reflecting long-term investments of $59.40 Million against total assets of $151.69 Million USD.
Lineage Cell Therapeutics Inc Long-term Investment Intensity by Year (2015–2018)
Lineage Cell Therapeutics Inc long-term investment intensity by year from 2015 to 2018. The table below presents the year-by-year Long-term Investment Intensity for Lineage Cell Therapeutics Inc from 2015 to 2018, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Lineage Cell Therapeutics Inc total assets.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 54.9% | $55.84 Million | $101.66 Million | ▼ -12.7 pp |
| 2017 | 67.6% | $117.17 Million | $173.24 Million | ▼ -2.5 pp |
| 2016 | 70.2% | $100.04 Million | $142.57 Million | ▲ +65.2 pp |
| 2015 | 4.9% | $4.67 Million | $94.66 Million | — |